GMCSF treatment associated with improved cognition in cancer patients

The same growth factor was previously shown to reverse memory decline in Alzheimer's mice

2012-06-22

(Press-News.org) Tampa, FL (June 22, 2012) – Growth factors shown to cure Alzheimer's disease in a mouse model and administered to cancer patients as part of their treatment regimen were linked to significant improvements in the patients' cognitive function following stem cell transplantation, a preliminary clinical study reports.

The findings by researchers at the USF Health Byrd Alzheimer's Institute and Moffitt Cancer Center are reported online in Brain Disorders & Therapy.

The retrospective study showed that cancer patients treated with granulocyte macrophage colony stimulating factor (GMCSF) plus granulocyte colony stimulating factor (GCSF) experienced greater improvement in memory and thinking than those treated with GCSF alone.

In the new study, the USF and Moffitt researchers investigated the link between GMCSF and cognitive functioning in humans for the first time, said principal investigator Huntington Potter, PhD, professor of molecular medicine at the USF Health Byrd Alzheimer's Institute. While the research looked at changes in cognition related to cancer treatment, it provided the basis for a new randomized controlled trial at the Byrd Alzheimer's Institute testing the safety and effectiveness of GMCSF (the drug sargramostim) in 40 patients with mild to moderate Alzheimer's disease.

GMCSF and GCSF, routinely administered to patients undergoing transplants to treat blood or bone marrow cancers, have a proven safety track record for this use. These growth, or colony stimulating, factors boost blood-forming stem cells circulating in the patient's own blood before the cells are harvested for autologous hematopoietic cell transplantation (HCT), speed the repopulation of cells depleted by chemotherapy or radiation, and/or fight infection in patients receiving bone marrow or blood stem cells from a donor.

Those involved in cancer research and clinical care are aware that problems with memory and concentration, referred to as "chemo brain," can be a side effect of high-dose chemotherapy, which is part of the regimen accompanying HCT.

Previous University of South Florida (USF) studies by Dr. Potter, Tim Boyd, PhD, and others investigated GMCSF and GCSF separately in mice bred to develop symptoms of Alzheimer's disease. They showed that these growth factors both reduce beta amyloid, a substance forming the hallmark plaques in the brain associated with Alzheimer's, and reverse memory impairment, with GMCSF being more effective.

"This preliminary work is an intriguing first step and points to the importance of collaboration between different health disciplines," said lead author Heather Jim, PhD, assistant professor in the Health Outcomes and Behavior Department at Moffitt. "While more research is needed, the study suggests that GMCSF, a drug with a relatively good safety profile, may be able to either prevent or reverse cognitive decline not only in Alzheimer's patients, but cancer patients as well."

The USF-Moffitt study involved 19 cancer patients who received GMCSF and GCSF, and 76 who received GCSF only. No patients received GMCSF only. Most were diagnosed with multiple myeloma or non-Hodgkin's lymphoma and treated with autologous HCT.

Neuropsychological tests of memory, attention and executive function (complex thinking) conducted before patients received GMCSF and/or GCSF for treatment with HCT indicated significant cognitive impairment in all study participants. The same tests six months after HCT showed that group of patients administered GMCSF and GCSF performed significantly better than the group receiving GCSF only – in the area of memory improvement. By 12 months, there were no differences; both groups had improved significantly in memory and executive function.

"The GMCSF was associated with faster cognitive recovery," Potter said.

The finding that GMCSF plus GCSF was associated with initially greater cognitive improvement than GCSF alone may reflect GMCSF's ability to mobilize a broader range of cell types, particularly the recruitment of more immune cells known as microglia that rush to damaged or inflamed areas to get rid of toxic substances, Potter said.

"Although preliminary and retrospective," he added, "the current data indicate that colony stimulating factors, particularly GMCSF, should be further tested as cognition enhancers for a number of different indications, including cancer and neurodegenerative disease."

###The USF randomized trial testing GMCSF in Alzheimer's patients is expected to be completed within a year. The university has submitted a patent for using GMCSF to treat cognitive decline.

USF Health's mission is to envision and implement the future of health. It is the partnership of the USF Health Morsani College of Medicine, the College of Nursing, the College of Public Health, the College of Pharmacy, the School of Biomedical Sciences and the School of Physical Therapy and Rehabilitation Sciences; and the USF Physician's Group. The University of South Florida is a global research university ranked 50th in the nation by the National Science Foundation for both federal and total research expenditures among all U.S. universities.

Located in Tampa, Moffitt Cancer Center is the only Florida-based National Cancer Institute Comprehensive Cancer Center, a designation that recognizes Moffitt's excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer.

ELSE PRESS RELEASES FROM THIS DATE:

For minority college students, STEM degrees pay big

2012-06-22

Minority college students who major in the STEM fields – science, technology, engineering and math – earn at least 25 percent more than their peers who study humanities or education, according to the results of a new study. And those who took jobs related to their STEM degrees earned at least 50 percent more than their classmates who majored in humanities or education fields. Published in the June issue of Research in Higher Education, the study followed more than 1,000 Asian and Pacific Islander, Latino and black students over nine years. The students were scholarship ...

Eurostar Becomes the Official Carrier of the French Paralympic Team

2012-06-22

Eurostar, the official international rail provider of the London 2012 Olympic and Paralympic Games, has announced details of a new partnership with the French National Paralympic Committee, which will see the high-speed rail operator proudly carry the French Paralympic team to the London 2012 Paralympic Games. Over the summer, Eurostar will carry the majority of the French Paralympians including the blind football, wheelchair rugby and wheelchair basketball teams to London on a specially chartered service on the 25 August and then again on their celebratory, homecoming ...

New Novel Inspired by Mary Magdalene, Mind Control, Tori Amos

2012-06-22

Sometimes only a child has the strength to face reality. In Mary and the Invisible Scaffolding, the new novel by author David Michael Conner, eight-year-old Mary's life in Cactus, Nevada comes to an abrupt end when her mother tears her from bed in the middle of the night and relocates them to lush, strange New Orleans. Bewildered, Mary must adapt to a new world with only her memories to guide her. "Initially, Mary was a short story inspired by the Tori Amos song 'Marys of the Sea (Les Saintes Maries de la Mer),'" said Conner. The Amos song is about the theory ...

Making bad worse for expectant mothers

2012-06-22

Some Norwegian women with birth anxiety face additional trauma in their meeting with the country's health service, according to research carried out in Stavanger. The Cesarean section rate is rising in most developed countries and many pregnant women around the world suffer from a fear of childbirth. In Norway, birth anxiety affects one in five pregnant women and can prompt some to demand a Caesarean delivery. But the question is how afraid a woman must be before her wishes are heard. Unlike many other countries, Norway does not give women an automatic right to a Caesarean ...

Danish scientists detect new immune alert signal

2012-06-22

Researchers from Aarhus University have now located the place in the human body where the earliest virus alert signal triggers the human immune system. They have also discovered a new alarm signal, which is activated at the very first sign of a virus attack. The groundbreaking finding has just been published in the highly esteemed scientific journal Nature Immunology. "It may turn out that patients suffering from frequent infections actually have problems with activating the mechanism that we have now detected," says Søren Riis Paludan, professor of immunology and virology ...

Research finds Stonehenge was monument marking unification of Britain

2012-06-22

After 10 years of archaeological investigations, researchers have concluded that Stonehenge was built as a monument to unify the peoples of Britain, after a long period of conflict and regional difference between eastern and western Britain. Its stones are thought to have symbolized the ancestors of different groups of earliest farming communities in Britain, with some stones coming from southern England and others from west Wales. The teams, from the universities of Sheffield, Manchester, Southampton, Bournemouth and University College London, all working on the Stonehenge ...

South African daffodils may be a future cure for depression

2012-06-22

Scientists at the University of Copenhagen have previously documented that substances from the South African plant species Crinum and Cyrtanthus – akin to snowdrops and daffodils – have an effect on the mechanisms in the brain that are involved in depression. This research has now yielded further results, since a team based at the Faculty of Health and Medical Sciences has recently shown how several South African daffodils contain plant compounds whose characteristics enable them to negotiate the defensive blood-brain barrier that is a key challenge in all new drug development. "Several ...

Maths tells us when to be more alert on the roads

2012-06-22

Technicians from Madrid City Council and a team of Pole and Spanish researchers have analysed the density and intensity of traffic on Madrid's M30 motorway (Spain) throughout the day. By applying mathematical algorithms, they have verified that drivers should pay more attention to the road between 6pm and 8pm to avoid accidents. Detection devices installed by the Department of Traffic Technologies of Madrid City Council on the M30 motorway and its access roads were used to conduct a scientific study. Researchers from SICE, the traffic management company in charge of ...

Michael Edelstein to Lead Licensing Practice at The Marketing Store

2012-06-22

The Marketing Store Worldwide, one of the world's largest privately held global brand activation agencies, announced today that Michael Edelstein has joined the agency as vice president, director of brand partnerships. Edelstein joins The Marketing Store from Learning Curve Brands, Inc where he was vice president, Preschool division. Edelstein will be based at The Marketing Store's Chicago office where he brings his licensing and partnership expertise to brand activations that The Marketing Store produces for its leading CPG (consumer packaged goods) and QSR (quick ...

Higher quality of life seen among regular moderate drinkers than among abstainers

2012-06-22

Data from a nationally representative sample of 5,404 community-dwelling Canadians ages 50 and older at baseline (1994/1995) was used to estimate the effects of alcohol drinking patterns on quality of life when subjects were aged =50 years and after a follow-up period. Health-related quality of life was assessed with the Health Utilities Index Mark 3 (HUI3). The authors report that most participants showed stable alcohol-consumption patterns over 6 years. Detailed information was available on the participants alcohol consumption. Moderate drinkers were defined as ...

GMCSF treatment associated with improved cognition in cancer patients

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: